JGC
GMED icon

J. Goldman & Co’s Globus Medical GMED Stock Holding History

J. Goldman & Co’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-204,827
Closed -$17.9M – 747
2025
Q4 		$17.9M Sell
204,827
-814,490
-80% -$61.8M 0.47% 56
2025
Q3 		$58.4M Buy
1,019,317
+387,569
+61% +$22.3M 1.47% 8
2025
Q2 		$37.3M Buy
+631,748
New +$40.8M 0.89% 18
2024
Q2 		– Sell
-291,873
Closed -$15.7M – 506
2024
Q1 		$15.7M Sell
291,873
-82,585
-22% -$4.44M 0.5% 55
2023
Q4 		$20M Sell
374,458
-455,246
-55% -$22.2M 0.81% 40
2023
Q3 		$41.2M Buy
829,704
+471,107
+131% +$26.3M 1.44% 11
2023
Q2 		$21.4M Sell
358,597
-154,493
-30% -$8.8M 0.78% 29
2023
Q1 		$29.1M Buy
+513,090
New +$32.9M 1.18% 15
2014
Q4 		– Sell
-150,000
Closed -$2.95M – 222
2014
Q3 		$2.95M Buy
+150,000
New +$3.09M 0.18% 148

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

J. Goldman & Co's GMED Position: Q1 2026 in Review

J. Goldman & Co sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 204,827 shares — an estimated $17.9M sold.

J. Goldman & Co first reported a position in GMED in Q3 2014 and held it in 9 quarters. The position peaked at $58.4M in Q3 2025. 607 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • J. Goldman & Co reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • J. Goldman & Co sold 204,827 Globus Medical shares in Q1 2026, an estimated $17.9M.
  • J. Goldman & Co first reported a position in Globus Medical in Q3 2014 and held it in 9 quarters.
  • J. Goldman & Co's Globus Medical position peaked at $58.4M in Q3 2025.
  • 607 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.